Orphan drugs


The FDA has authority to grant orphan-drug designation to a drug or biological product to prevent, diagnose or treat a rare disease or condition. Orphan drug designation qualifies sponsors for incentives including: Tax credits for qualified clinical trials. What is the Orphan Drug Act? The Orphan Drug Act is a law passed by Congress in 1983 that incentivizes the development of drugs to treat rare diseases. Companies and other drug developers can request orphan drug designation and FDA will grant such designation if the drug meets specific criteria.



 


    Related Conference of Orphan drugs

    March 27-28, 2023

    16th Global Pharmacovigilance & Clinical Trials Summit

    Vancouver, Canada
    April 03-04, 2023

    16th European Biosimilars Congress

    Barcelona, Spain
    April 25-26, 2023

    4th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 07-08, 2023

    Advanced-Materials 2023

    Valencia, Spain
    July 06-07, 2023

    5th World Congress on Drug Discovery and Drug Design

    Vancouver, Canada
    July 25-26, 2023

    36th World Congress on Pharmacology

    Amsterdam, Netherlands
    August 11-12, 2023

    38th World Congress on Pharmacology and Therapeutics

    Singapore City, Singapore
    August 28-29, 2023

    23rd International Pharmaceutical Conference and Expo

    Vancouver, Canada
    September 06-07, 2023

    16th World Drug Delivery Summit

    London, UK
    September 14-15, 2023

    10th international conference on Physiotherapy

    Bangkok, Thailand
    September 27-28, 2023

    3rd World Congress on Rare Diseases & Orphan Drugs

    Amsterdam, Netherlands
    September 27-28, 2023

    8th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 09-10, 2023

    20th International Conference on Pharmaceutical Chemistry

    Barcelona, Spain
    October 12-13, 2023

    26th World Congress on Nursing, Pharmacology and Healthcare

    Budapest, Hungary
    November 09-10, 2023

    11th International Conference on Clinical Trials

    London, UK
    November 10-11, 2023

    3rd World Biosimilars & Biologics Congress

    Berlin, Germany
    December 05-06, 2023

    2nd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Orphan drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in